Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN previous answer version answering member constituency answering member printed question first answered question first ministerially corrected answering member label attachment file name title
tabling member	label

Search

77415

registered interest
date	11/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Idiopathic Pulmonary Fibrosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how much his Department has spent on research into idiopathic pulmonary fibrosis in each of the last three years.
tabling member constituency	Stockton North
tabling member printed	Alex Cunningham
uin	205398
answer	answer is ministerial correction date of answer 21/07/2014 answer text <p>Expenditure by the Department’s National Institute for Health Research (NIHR) through research programmes, research centres and units, and research fellowships on research on idiopathic pulmonary fibrosis is shown in the following table.</p><p> </p><table><tbody><tr><td><p>2011-12</p><p>£ million</p></td><td><p>2012-13</p><p>£ million</p></td><td><p>2013-14</p><p>£ million</p></td></tr><tr><td><p>0.1</p></td><td><p>0.3</p></td><td><p>0.6</p></td></tr></tbody></table><p> </p><p>Total spend by the NIHR on research on this disease is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on idiopathic pulmonary fibrosis cannot be disaggregated from total CRN expenditure.</p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 21/07/2014 16:40:04 answering member 3932 label Biography information for Dr Dan Poulter
tabling member	4122 label Biography information for Alex Cunningham

77416

registered interest
date	11/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Idiopathic Pulmonary Fibrosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to reduce deaths from idiopathic pulmonary fibrosis.
tabling member constituency	Stockton North
tabling member printed	Alex Cunningham
uin	205399
answer	answer is ministerial correction date of answer 21/07/2014 answer text <p>Reducing mortality and improving outcomes for people with respiratory disease is a key priority for this Government. It is specifically covered in both the Public Health and NHS Outcome Frameworks. NHS England is working to improve the quality of NHS services, and will be held to account through the Mandate.</p><p> </p><p>The responsibility for the commissioning of services for interstitial lung disease (ILD) sits under the umbrella of specialised commissioning within NHS England. It has published a service specification for ILD at:</p><p> </p><p>www.england.nhs.uk/wp-content/uploads/2013/06/a14-respiratory-inters-lung.pdf</p><p> </p><p>Pages 3 and 4 of this specification set out the overall aim of the specialist service and how a standardised approach to treatment across the country should be delivered.</p><p> </p><p>In line with the implementation of all specialised commissioning specifications, NHS England is undertaking a compliance programme assessing all current providers of ILD services against a set of key requirements from the specification.</p><p> </p><p>Area Teams are now working with providers to commission the services and once arrangements have been agreed then the list of ILD centres will be made public. We expect this exercise to be completed later in the year.</p><p> </p><p>In April 2013, the National Institute of Health and Care Excellence (NICE) published a technology appraisal advising on the use of Pirfenidone as a treatment for idiopathic pulmonary fibrosis (IPF). In June 2013, NICE published its first clinical guideline on the diagnosis and management of IPF. The use of other treatments for the management of ILD are also covered by the NICE guidelines. We expect commissioners to have regard to NICE guidelines when commissioning services.</p><p> </p><p>NHS England funds the treatment of patients with Pirfenidone, in line with the NICE appraisal, from centres that are contracted to provide specialised services for patients with ILD.</p><p> </p><p>There were no awareness raising campaigns specifically targeted at IFP in the specified timeframe. Though IPF was not directly referenced, Public Health England recently ran a local pilot campaign in Oldham and Rochdale to raise awareness amongst the public about the importance of visiting their general practitioner with symptoms of breathlessness.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 205400 205401 205402 question first answered 21/07/2014 16:13:34 answering member 3918 label Biography information for Jane Ellison
tabling member	4122 label Biography information for Alex Cunningham

77418

registered interest
date	11/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Idiopathic Pulmonary Fibrosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department plans to take to ensure that the 2013 idiopathic pulmonary fibrosis guidelines, drawn up by the National Institute for Health and Care Excellence, are fully implemented.
tabling member constituency	Stockton North
tabling member printed	Alex Cunningham
uin	205400
answer	answer is ministerial correction date of answer 21/07/2014 answer text <p>Reducing mortality and improving outcomes for people with respiratory disease is a key priority for this Government. It is specifically covered in both the Public Health and NHS Outcome Frameworks. NHS England is working to improve the quality of NHS services, and will be held to account through the Mandate.</p><p> </p><p>The responsibility for the commissioning of services for interstitial lung disease (ILD) sits under the umbrella of specialised commissioning within NHS England. It has published a service specification for ILD at:</p><p> </p><p>www.england.nhs.uk/wp-content/uploads/2013/06/a14-respiratory-inters-lung.pdf</p><p> </p><p>Pages 3 and 4 of this specification set out the overall aim of the specialist service and how a standardised approach to treatment across the country should be delivered.</p><p> </p><p>In line with the implementation of all specialised commissioning specifications, NHS England is undertaking a compliance programme assessing all current providers of ILD services against a set of key requirements from the specification.</p><p> </p><p>Area Teams are now working with providers to commission the services and once arrangements have been agreed then the list of ILD centres will be made public. We expect this exercise to be completed later in the year.</p><p> </p><p>In April 2013, the National Institute of Health and Care Excellence (NICE) published a technology appraisal advising on the use of Pirfenidone as a treatment for idiopathic pulmonary fibrosis (IPF). In June 2013, NICE published its first clinical guideline on the diagnosis and management of IPF. The use of other treatments for the management of ILD are also covered by the NICE guidelines. We expect commissioners to have regard to NICE guidelines when commissioning services.</p><p> </p><p>NHS England funds the treatment of patients with Pirfenidone, in line with the NICE appraisal, from centres that are contracted to provide specialised services for patients with ILD.</p><p> </p><p>There were no awareness raising campaigns specifically targeted at IFP in the specified timeframe. Though IPF was not directly referenced, Public Health England recently ran a local pilot campaign in Oldham and Rochdale to raise awareness amongst the public about the importance of visiting their general practitioner with symptoms of breathlessness.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 205399 205401 205402 question first answered 21/07/2014 16:13:34 answering member 3918 label Biography information for Jane Ellison
tabling member	4122 label Biography information for Alex Cunningham

77419

registered interest
date	11/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Idiopathic Pulmonary Fibrosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how much funding his Department provided for awareness-raising work for idiopathic pulmonary fibrosis in (a) 2011, (b) 2012 and (c) 2013.
tabling member constituency	Stockton North
tabling member printed	Alex Cunningham
uin	205401
answer	answer is ministerial correction date of answer 21/07/2014 answer text <p>Reducing mortality and improving outcomes for people with respiratory disease is a key priority for this Government. It is specifically covered in both the Public Health and NHS Outcome Frameworks. NHS England is working to improve the quality of NHS services, and will be held to account through the Mandate.</p><p> </p><p>The responsibility for the commissioning of services for interstitial lung disease (ILD) sits under the umbrella of specialised commissioning within NHS England. It has published a service specification for ILD at:</p><p> </p><p>www.england.nhs.uk/wp-content/uploads/2013/06/a14-respiratory-inters-lung.pdf</p><p> </p><p>Pages 3 and 4 of this specification set out the overall aim of the specialist service and how a standardised approach to treatment across the country should be delivered.</p><p> </p><p>In line with the implementation of all specialised commissioning specifications, NHS England is undertaking a compliance programme assessing all current providers of ILD services against a set of key requirements from the specification.</p><p> </p><p>Area Teams are now working with providers to commission the services and once arrangements have been agreed then the list of ILD centres will be made public. We expect this exercise to be completed later in the year.</p><p> </p><p>In April 2013, the National Institute of Health and Care Excellence (NICE) published a technology appraisal advising on the use of Pirfenidone as a treatment for idiopathic pulmonary fibrosis (IPF). In June 2013, NICE published its first clinical guideline on the diagnosis and management of IPF. The use of other treatments for the management of ILD are also covered by the NICE guidelines. We expect commissioners to have regard to NICE guidelines when commissioning services.</p><p> </p><p>NHS England funds the treatment of patients with Pirfenidone, in line with the NICE appraisal, from centres that are contracted to provide specialised services for patients with ILD.</p><p> </p><p>There were no awareness raising campaigns specifically targeted at IFP in the specified timeframe. Though IPF was not directly referenced, Public Health England recently ran a local pilot campaign in Oldham and Rochdale to raise awareness amongst the public about the importance of visiting their general practitioner with symptoms of breathlessness.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 205399 205400 205402 question first answered 21/07/2014 16:13:34 answering member 3918 label Biography information for Jane Ellison
tabling member	4122 label Biography information for Alex Cunningham

77421

registered interest
date	11/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Idiopathic Pulmonary Fibrosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, when the allocation of interstitial lung disease specialist centres will be completed; and when his Department will publish the location of these centres.
tabling member constituency	Stockton North
tabling member printed	Alex Cunningham
uin	205402
answer	answer is ministerial correction date of answer 21/07/2014 answer text <p>Reducing mortality and improving outcomes for people with respiratory disease is a key priority for this Government. It is specifically covered in both the Public Health and NHS Outcome Frameworks. NHS England is working to improve the quality of NHS services, and will be held to account through the Mandate.</p><p> </p><p>The responsibility for the commissioning of services for interstitial lung disease (ILD) sits under the umbrella of specialised commissioning within NHS England. It has published a service specification for ILD at:</p><p> </p><p>www.england.nhs.uk/wp-content/uploads/2013/06/a14-respiratory-inters-lung.pdf</p><p> </p><p>Pages 3 and 4 of this specification set out the overall aim of the specialist service and how a standardised approach to treatment across the country should be delivered.</p><p> </p><p>In line with the implementation of all specialised commissioning specifications, NHS England is undertaking a compliance programme assessing all current providers of ILD services against a set of key requirements from the specification.</p><p> </p><p>Area Teams are now working with providers to commission the services and once arrangements have been agreed then the list of ILD centres will be made public. We expect this exercise to be completed later in the year.</p><p> </p><p>In April 2013, the National Institute of Health and Care Excellence (NICE) published a technology appraisal advising on the use of Pirfenidone as a treatment for idiopathic pulmonary fibrosis (IPF). In June 2013, NICE published its first clinical guideline on the diagnosis and management of IPF. The use of other treatments for the management of ILD are also covered by the NICE guidelines. We expect commissioners to have regard to NICE guidelines when commissioning services.</p><p> </p><p>NHS England funds the treatment of patients with Pirfenidone, in line with the NICE appraisal, from centres that are contracted to provide specialised services for patients with ILD.</p><p> </p><p>There were no awareness raising campaigns specifically targeted at IFP in the specified timeframe. Though IPF was not directly referenced, Public Health England recently ran a local pilot campaign in Oldham and Rochdale to raise awareness amongst the public about the importance of visiting their general practitioner with symptoms of breathlessness.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 205399 205400 205401 question first answered 21/07/2014 16:13:34 answering member 3918 label Biography information for Jane Ellison
tabling member	4122 label Biography information for Alex Cunningham

77479

registered interest
date	11/07/2014
answering body	Department for Transport
answering dept id	27
answering dept short name	Transport
answering dept sort name	Transport
hansard heading	Shipping: Oil
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Transport, which oil transfer licences have been (a) applied for and (b) consented under the Merchant Shipping (Ship-to-Ship Transfers) Regulations 2010 as amended to date.
tabling member constituency	Edinburgh North and Leith
tabling member printed	Mark Lazarowicz
uin	205409
answer	answer is ministerial correction date of answer 17/07/2014 answer text <p> </p><p>To date the Maritime and Coastguard Agency (MCA) has received five applications for an Oil Transfer Licence.</p><p> </p><p>Of these three have been consented. These are:</p><p> </p><p>• Shetland Island Council - Sullom Voe;</p><p>• Cromarty Firth Port Authority - Nigg Oil Terminal; and</p><p>• Port of Grangemouth.</p><p>The fourth application for the Finnart Ocean Terminal (Loch Fyne) has completed consultation and has been assessed by the MCA. A final decision is pending, awaiting legal clarification.</p><p> </p><p>The fifth application, for Ship to Ship Transfers in Scapa Flow, has just been received and went out to public consultation on 10 July 2014.</p> answering member constituency South Holland and The Deepings answering member printed Mr John Hayes question first answered 17/07/2014 14:29:22 answering member 350 label Biography information for Sir John Hayes
tabling member	1411 label Biography information for Mark Lazarowicz

77480

registered interest
date	11/07/2014
answering body	Department for Transport
answering dept id	27
answering dept short name	Transport
answering dept sort name	Transport
hansard heading	Shipping: Oil
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Transport, what role is played by (a) Ministers in the Scottish Government, (b) Scottish Natural Heritage and (c) the Scottish Environmental Protection Agency in the consenting process for oil transfer licences made under the Merchant Shipping (Ship-to-Ship Transfers) Regulations 2010.
tabling member constituency	Edinburgh North and Leith
tabling member printed	Mark Lazarowicz
uin	205410
answer	answer is ministerial correction date of answer 17/07/2014 answer text <p><strong> </strong></p><p>The Local Government Authority, in whose area the proposed site is situated, is always consulted as part of the public consultation process that accompanies an application for an Oil Transfer Licence within the UK. Members of Parliament or the Scottish Parliament may get involved in the public consultation, as may Ministers in the Scottish Government, by replying to the consultation.</p><p> </p><p>Both Scottish Natural Heritage and the Scottish Environmental Protection Agency are among the mandatory consultees for all applications for an Oil Transfer Licence, where the application is for a location in Scotland.</p><p> </p><p>The Maritime and Coastguard Agency, acting on behalf of the Secretary of State for Transport, is the Competent Authority for managing, assessing and issuing Oil Transfer Licenses within the UK. This is a reserved matter for the UK Government.</p><p> </p> answering member constituency South Holland and The Deepings answering member printed Mr John Hayes question first answered 17/07/2014 15:44:18 answering member 350 label Biography information for Sir John Hayes
tabling member	1411 label Biography information for Mark Lazarowicz

76999

registered interest
date	10/07/2014
answering body	Department for Business, Innovation and Skills
answering dept id	26
answering dept short name	Business, Innovation and Skills
answering dept sort name	Business, Innovation and Skills
hansard heading	Small Businesses: Ashfield
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Innovation and Skills, how many small and medium-sized enterprises have been started in Ashfield constituency in each of the last five years; and what proportion of such businesses are still trading.
tabling member constituency	Ashfield
tabling member printed	Gloria De Piero
uin	205156
answer	answer is ministerial correction date of answer 28/08/2014 answer text <p>There is no single data source that comprehensively measures all business start-ups within the UK. However, as a near proxy BankSearch collates data on the number of new business bank accounts opened in Great Britain. This can be used as an indicative measure of business start-up activity and is the most comprehensive source available to BIS. Data goes as far back as 2008 and does not include information on whether the business is trading or not.</p><p> </p><p> </p><p> </p> answering member constituency West Suffolk answering member printed Matthew Hancock question first answered 28/08/2014 15:16:40 answering member 4070 label Biography information for Matt Hancock attachment 1 file name Ashfield - SME start-ups.docx title SME start-ups in Ashfield constituency
tabling member	3915 label Biography information for Gloria De Piero

77050

registered interest
date	10/07/2014
answering body	Department for Communities and Local Government
answering dept id	7
answering dept short name	Communities and Local Government
answering dept sort name	Communities and Local Government
hansard heading	Help to Buy Scheme: South East
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Communities and Local Government, how many house purchases have been funded through the Help to Buy scheme in (a) Brighton, Kemptown constituency, (b) Sussex and (c) South East England to date.
tabling member constituency	Brighton, Kemptown
tabling member printed	Simon Kirby
uin	205245
answer	answer is ministerial correction date of answer 17/07/2014 answer text <p> </p><p>This Government is committed to supporting people's aspirations to own their own home. The Department's official statistics on sales for the Help to Buy: Equity Loan scheme, as of 31 May, broken down by local authority and postcode sector for England, are available at: <a href="http://www.gov.uk/government/statistical-data-sets/help-to-buy-equity-loan-scheme-monthly-statistics" target="_blank">www.gov.uk/government/statistical-data-sets/help-to-buy-equity-loan-scheme-monthly-statistics</a>.</p><p>Figures are not available by constituency. In the areas of Brighton and Hove, and Lewes which covers all of the Brighton, Kemptown constituency, the number of families buying a home with the support of the Help to Buy: Equity Loan scheme is four and zero, respectively. Equivalent figures for Help to Buy: NewBuy are two and six.</p><p>The number of families buying a home with the support of the Help to Buy: Equity Loan scheme in Sussex is 591. 104 families have bought a home with the support of Help to Buy: NewBuy.</p><p>My Department does not publish regional statistics.</p><p>The Help to Buy: Mortgage Guarantee scheme is managed by HM Treasury and the data is available at: <a href="http://www.gov.uk/government/publications/help-to-buy-mortgage-guarantee-scheme-quarterly-statistics-october-2013-to-march-2014" target="_blank">www.gov.uk/government/publications/help-to-buy-mortgage-guarantee-scheme-quarterly-statistics-october-2013-to-march-2014</a>.</p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Great Yarmouth answering member printed Brandon Lewis question first answered 17/07/2014 15:05:17 answering member 4009 label Biography information for Sir Brandon Lewis
tabling member	3929 label Biography information for Simon Kirby

77093

registered interest
date	10/07/2014
answering body	Ministry of Defence
answering dept id	11
answering dept short name	Defence
answering dept sort name	Defence
hansard heading	Armed Forces: Official Residences
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Defence, what the cost to the public purse was of running and maintaining each grace and favour residence provided by his Department to senior figures from the armed forces in each year since 2010.
tabling member constituency	North Durham
tabling member printed	Mr Kevan Jones
uin	205237
answer	answer is ministerial correction date of answer 07/08/2014 answer text <p>Under previous arrangements, Official Service Residences (OSRs, colloquially known as ‘grace and favour’ residencies) were provided for senior officers in certain posts which required them to undertake official hospitality for Defence purposes. As announced by the then Minister for Personnel, Welfare and Veterans (Andrew Robathan) on 12 December 2011 (Official Report, column 63WS), these arrangements have been discontinued. Properties which were formerly categorised as OSRs are being phased out on a rolling basis as personnel retire or move on to other posts. However, senior officers remain entitled to Service Family Accommodation (Type 1 or Type 2). In addition, the Department is undertaking an ongoing review into domestic assistance policy to ensure that the level of support provided to senior entitled officers is appropriate and driven by a clear business need. Information is available for financial years 2009-10 and 2010-11 and is presented in the tables.</p> answering member constituency Broxtowe answering member printed Anna Soubry previous answer version 11770 answering member constituency Broxtowe answering member printed Anna Soubry answering member 3938 label Biography information for Anna Soubry 15385 answering member constituency Broxtowe answering member printed Anna Soubry answering member 3938 label Biography information for Anna Soubry attachment 1 file name Tables - Part of answer to 205237.doc title Tables forming part of the answer to 205237 question first answered 07/08/2014 10:44:05 question first ministerially corrected 16/02/2015 10:06:13 answering member 3938 label Biography information for Anna Soubry attachment 1 file name Tables - Part of answer to 205237 FINAL.doc title Tables forming part of the answer to 205237 v3
tabling member	1438 label Biography information for Mr Kevan Jones